SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|
| Glyicti | 1.1 g/ml | Oral liquid · Oral use | 1 Bottle | SAR 1198.55 | Generic · Prescription | Saudi Amarox | Valid |
| Ravicti | 1.1 g/ml | Oral liquid · Oral use | 1 Bottle | SAR 1198.55 | NCE · Prescription | Immedica Pharma AB | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
EMA European Union — centrally authorised medicines
Ravicti Immedica Pharma AB · Authorised · authorised 26 Nov 2015 · ATC A16AX09
Therapeutic indication (EMA)
Ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (UCDs) including deficiencies of carbamoyl phosphate-synthase-I (CPS), ornithine carbamoyltransferase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase I (ARG) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. Ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|
| RAVICTI | 02453304 | 1.1 G / ML | LIQUID · ORAL | HORIZON THERAPEUTICS IRELAND DAC |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.